Last updated on June 2012

MBB102073: A clinical research study for subjects with Diabetes Mellitus, Type 2.


Brief description of study

MBB102073: A clinical research study for subjects with Diabetes Mellitus, Type 2.

Detailed Study Description

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapaglifozin in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB).

Please contact us for eligibility criteria.

Clinical Study Identifier: TX136039

Find a site near you

Start Over

Advanced Medical Concepts PSC

4 Baldorioty St. Cidra, XX Puerto Rico
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.